Boehringer In­gel­heim deep­ens its col­lab­o­ra­tion with Click Ther­a­peu­tics in a deal worth $460M

Boehringer In­gel­heim inked a mas­sive col­lab­o­ra­tion with dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics two years ago — and now its ex­pand­ing.

On Mon­day, the Ger­man phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER